Cognitive-Behavioral Therapy for Schizophrenia

Search Google for cognitive-behavioral therapy (CBT) and you’ll find this: “A type of psychotherapy in which negative patterns of thought about the self and the world are challenged in order to alter unwanted behavior patterns or treat mood disorders such as depression.” On the surface, it seems unlikely that this type of therapy would be associated with people suffering from schizophrenia, a serious mental disorder affecting approximately one percent of the world’s population. But it may be an effective supplementary therapy to pharmacological treatment for those with the disorder. Post-hospital care often begins while patients are still in the hospital, and applies the principles of treatment engagement, goal-setting, positive actions and removing roadblocks to recovery (Moran, 2014). It is believed that utilizing these ideas will allow patients to assume more control in their daily lives and allow for a return of functionality where they may previously have lost some. CBT is considered an effective way to apply these principles and teach the patient how to practice them on their own. It is the most universal treatment in addition to medication in the UK, as well as recommended to become a second frontline treatment by the UK National Health Service (, 2014). According to the Beck Institute website (2016), “the goal of CBT is to help people get better and stay better.” The website also explains that the therapy is a platf...
Source: Psych Central - Category: Psychiatry Authors: Tags: Cognitive-Behavioral Disorders General Medications Psychotherapy Schizophrenia Treatment Beck Institute Behaviour therapy Cognitive Behavioral Therapy Depression Mental Disorder Mental Health Psychiatry Psychology Psychosis Source Type: news

Related Links:

This study found that individuals with schizophrenia have increased levels of antibodies to certain EBV proteins.Schizophrenia Bulletin
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news
Today is Blue Monday, which is rumored to be the most depressing day of the year. But is it? Research hasn't proved that there is any one day more depressing than all the others. It's a PR stunt that has cemented itself into modern culture.
Source: - Health - Category: Consumer Health News Source Type: news
Publication date: Available online 18 January 2020Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Shaoqiang Han, Qian Cui, Xiao Wang, Yuyan Chen, Di Li, Liang Li, Xiaonan Guo, Yun-Shuang Fan, Jing Guo, Wei Sheng, Feng-Mei Lu, Zongling He, Huafu ChenAbstractDuring depressive episode, bipolar disorder (BD) patients share indistinguishable depression symptoms with major depressive disorder (MDD).However, whether neural correlates underlying the anhedonia, a core feature of depression, is different between BD and MDD remains unknown. To explore neural correlates underlying the anhedonia in BD a...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
Publication date: Available online 18 January 2020Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Ryo Ochi, Yoshihiro Noda, Shohei Tsuchimoto, Ryosuke Tarumi, Shiori Honda, Karin Matsushita, Sakiko Tsugawa, Eric Plitman, Fumi Masuda, Kamiyu Ogyu, Masataka Wada, Takahiro Miyazaki, Shinya Fujii, M. Mallar Chakravarty, Ariel Graff-Guerrero, Hiroyuki Uchida, Masaru Mimura, Shinichiro NakajimaAbstractPrevious diffusion tensor imaging (DTI) studies have reported white matter alterations in patients with schizophrenia. Notably, one third of this population does not respond to first-line antipsycho...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
This article is intended to provide an overview of the literature regarding mental disorders associated with polycystic ovary syndrome and to present own research on depression and sexual dysfunction in this group. PMID: 31760419 [PubMed - in process]
Source: Psychiatria Polska - Category: Psychiatry Tags: Psychiatr Pol Source Type: research
It’s common knowledge that psychiatric medications are prone to sexual side effects. It’s often referenced in the advertising. Since most people living with mental illness want to be both happy and have a satisfying sex life, this creates a bit of a quandary Are the two things mutually exclusive? What does a person on psychiatric medications do when the cure seems worse than the illness? Listen in to find out now! SUBSCRIBE &REVIEW “The sexual side effects of [psychiatric] medications are the number one reason people stop taking them.” – Gabe Highlights from ‘Medication Sexual ...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: A Bipolar, A Schizophrenic, and a Podcast Antidepressant Antipsychotic Medications Schizophrenia Women's Issues Source Type: blogs
Conclusions: The findings from this exploratory study are consistent with the possibility that dialogue therapy may lead to improvements in symptoms and functioning compared to standard treatment in psychosis. Introduction Standard treatment (ST) for psychosis consists primarily of antipsychotics, hospitalization, social rehabilitation, and different types of supportive therapy (1–3). Antipsychotic drugs have only moderate effects on positive symptoms and no demonstrable effects on negative symptoms (4–6). Side effects are often prominent and might include a reduction in emotional expression, menstrual ...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Conclusion: This novel technology discriminates and quantifies subtle differences in behavior and neurological impairments in subjects afflicted with neurological injury/disease. KINARM assessments can be incorporated into multi-center trials (e.g., monitoring stroke motor recovery: NCT02928393). Further studies will determine if KINARM Labs can demonstrate a clinical effect with fewer subjects over a shorter trial period. Disclosures/funding: Dr. Stephen Scott is the inventor of KINARM and CSO of BKIN Technologies.   Multiplexed mass spectrometry assay identifies neurodegeneration biomarkers in CSF Presenter: Chelsky...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Assessment Tools biomarkers Cognition Current Issue Drug Development General Genetics Medical Issues Neurology Patient Assessment Psychopharmacology Scales Special Issues Supplements Trial Methodology clinical trials CNS Su Source Type: research
AbstractThis descriptive and cross-sectional study aimed to evaluate the specific factors that influence the sex lives of psychiatric patients. The study sample consisted of patients who received care in the psychiatry department of a university hospital (N  = 200). Data were collected using a questionnaire developed according to information available in the literature and the Arizona Sexual Experience Scale. The mean age of the patients in the study was 36.70 ± 10.34 years. Additionally, 58% (n = 116) of the patients were female, and 42% (n =  84) were male. The diagnost...
Source: Sexuality and Disability - Category: Disability Source Type: research
CONCLUSION: Considering the significant relative frequency of sexual dysfunction in psychiatric patients and undesired effects of simultaneous occurrence of both of these disorders in the patients, more emphasis is recommended to be placed on the prevention and proper treatment of these disorders in the patients. PMID: 26623400 [PubMed - as supplied by publisher]
Source: Biomed Res - Category: Research Authors: Tags: Adv Biomed Res Source Type: research
More News: Anxiety | Behavioural Therapy | Cognitive Behavior Therapy | Depression | Health | Hospitals | Learning | Legislation | Men | National Health Service (NHS) | National Institute for Health and Clinical Excelle | Occupational Health | Psychiatry | Psychology | Psychotherapy | Schizophrenia | Sexual Dysfunction | Study | Teaching | UK Health | Universities & Medical Training | Websites